Zobrazeno 1 - 6
of 6
pro vyhledávání: '"N. O. Shurko"'
Publikováno v:
Біологічні студії, Vol 11, Iss 1, Pp 67-74 (2017)
The problem of processing of donor plasma for creating an effective medications is important. Nowadays a big number of methods for fractionation of plasma separation and purification components, especially coagulation factors and fibrinolysis were de
Externí odkaz:
https://doaj.org/article/622cb6a3d18949879a016529a2964378
Publikováno v:
Біологічні студії, Vol 8, Iss 1, Pp 197-204 (2014)
To correct factor deficiency or prevent bleeding in patients with hemophilia A, the replacement therapy is carried out. This therapy involves administrating plasma or recombinant preparations of factor VIII. A variety of plasma- and recombinant-deriv
Externí odkaz:
https://doaj.org/article/f9aacbc0ad334e198b74ab90139eab70
Autor:
N. O. Shurko, V. L. Novak
Publikováno v:
Scientific Issue Ternopil Volodymyr Hnatiuk National Pedagogical University. Series: Biology. 79:102-108
The article deals with basic methods used by modern technology to obtain coagulation factor VIII (FVIII). The blood plasma fractionation remains the only biotechnological approach to make life-saving protein therapy to treat human diseases. The biolo
Autor:
N. O. Shurko, T. V. Danysh
Publikováno v:
The Animal Biology. 18:152-159
Publikováno v:
Біологічні студії, Vol 8, Iss 1, Pp 197-204 (2014)
To correct factor deficiency or prevent bleeding in patients with hemophilia A, the replacement therapy is carried out. This therapy involves administrating plasma or recombinant preparations of factor VIII. A variety of plasma- and recombinant-deriv
Autor:
N. O. Shurko, T. V. Danysh
Publikováno v:
Hematology & blood transfusion: interdepartamental collection.